ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,555.74
      -0.19%
      US Tech 100
      19,224.80
      0.00%
      Dow Jones
      40,358.09
      -0.14%
      Brent Oil
      80.595
      -0.22%
      Bitcoin
      66,096.77
      0.26%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Canada
      5. TSX

      6. Medicenna Therapeutics Corp (MDNA) Quote

      Medicenna Therapeutics Corp

      Medicenna Therapeutics Corp (MDNA)

      Medicenna Therapeutics Corporation
      1.95
      0.00
      (0.00%)
      Closed July 24 4:12PM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      1.95
      Bid
      1.93
      Ask
      1.98
      Volume
      32,276
      1.92 Day's Range 1.96
      0.215 52 Week Range 2.98
      Market Cap
      135.792M
      Previous Close
      1.95
      Open
      1.96
      Last Trade
      300
      @
      1.95
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      111,886
      Shares Outstanding
      69,637,000
      Dividend Yield
      -
      PE Ratio
      -5.33
      Earnings Per Share (EPS)
      -0.37
      Revenue
      -
      Net Profit
      -25.47M

      About Medicenna Therapeutics Corp

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.medicenna.com
      Headquarters
      Toronto, Ontario, Can
      Founded
      1970
      Medicenna Therapeutics Corp is listed in the Biological Pds,ex Diagnstics sector of the Toronto Stock Exchange with ticker MDNA. The last closing price for Medicenna Therapeutics was $1.95. Over the last year, Medicenna Therapeutics shares have traded in a share price range of $ 0.215 to $ 2.98.

      Medicenna Therapeutics currently has 69,637,000 shares outstanding. The market capitalization of Medicenna Therapeutics is $135.79 million. Medicenna Therapeutics has a price to earnings ratio (PE ratio) of -5.33.

      MDNA Latest News

      More News

      Medicenna Therapeutics Reports Fiscal Year 2024 Financial Results and Operational Highlights

      Increased cash balance to $37 million following a $20 million investment by RA Capital extending runway into mid-2026 MDNA11 continues to exhibit compelling deep and durable single agent activity...

      June 27 2024
      GlobeNewswire Inc.

      Medicenna Announces EMA Approval of its Clinical Trial Application to Expand its Phase 1/2 ABILITY-1 Study to Europe

      - ABILITY-1 study is currently enrolling patients for the treatment of advanced solid tumors with MDNA11, a novel long-acting IL-2 super-agonist, as a monotherapy or in combination with KEYTRUDA®...

      June 26 2024
      GlobeNewswire Inc.

      Medicenna Reports Significant Survival Benefit in Patients with Recurrent Glioblastoma Following Treatment with Bizaxofusp When Compared to a Matched External Control Arm at the 2024 ASCO Annual Meeting

      Single treatment with bizaxofusp achieved significant survival benefit (mOS of 13.5 vs. 7.2 months, p=0.009) and reduced risk of death by almost half (hazard ratio: 0.54, 95% confidence interval:...

      June 03 2024
      GlobeNewswire Inc.

      Medicenna To Present Evidence of Durable Single Agent Activity and Potent Immune Effector Response with MDNA11 in the Dose Escalation Portion of Phase 1/2 ABILITY-1 Study at the 10th Annual Oncology Innovation Forum

      MDNA11 demonstrates durable response in pancreatic cancer patient with 100% regression of target and non-target lesions for over 104 weeks and continues to show remission 4 months after stopping...

      May 31 2024
      GlobeNewswire Inc.

      Medicenna to Present Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming Sachs 10th Annual Oncology Innovation Forum

      TORONTO and HOUSTON, May 22, 2024 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQB: MDNAF), a clinical-stage immunotherapy company...

      May 22 2024
      GlobeNewswire Inc.

      Medicenna Provides Update on its Presentations at the 2024 ASCO Annual Meeting

      ASCO has informed the Company that the previously accepted MDNA11 oral abstract has been withdrawn due to alleged violation of their prior publication policy based solely on their review of the...

      May 13 2024
      GlobeNewswire Inc.

      Medicenna Therapeutics Announces Closing of CA$20 Million Investment from RA Capital Management

      Not for distribution to United States news wire services or for dissemination in the United States TORONTO and HOUSTON, April 30, 2024 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp...

      April 30 2024
      GlobeNewswire Inc.

      L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - MDNA

      L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - MDNA Canada NewsWire TORONTO, le 26 avril 2024 TORONTO, le 26 avril 2024 /CNW/...

      April 26 2024
      PR Newswire (Canada)

      Canadian Investment Regulatory Organization Trade Resumption - MDNA

      Canadian Investment Regulatory Organization Trade Resumption - MDNA Canada NewsWire TORONTO, April 26, 2024 TORONTO, April 26, 2024 /CNW/ - Trading resumes in: Company: Medicenna Therapeutics...

      April 26 2024
      PR Newswire (Canada)

      Suspension de la négociation par l'Organisme canadien de réglementation des investissements - MDNA

      Suspension de la négociation par l'Organisme canadien de réglementation des investissements - MDNA Canada NewsWire TORONTO, le 26 avril 2024 TORONTO, le 26 avril 2024 /CNW/...

      April 26 2024
      PR Newswire (Canada)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.1-4.878048780492.052.171.86556791.99413848CS
      4-0.08-3.940886699512.032.251.77775821.97806484CS
      12-0.3-13.33333333332.252.981.641118862.27403438CS
      261.495328.5714285710.4552.980.411382251.82787978CS
      521.39248.2142857140.562.980.2151023271.36644248CS
      156-0.97-33.21917808222.923.670.215626641.5473976CS
      2600.5943.38235294121.367.250.215735422.72749029CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      AAGRAfrican Agriculture Holdings Inc
      $ 0.1629
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 63.09
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 1.57
      (0.00%)
      		0
      AACIArmada Acquisition Corporation I
      $ 11.30
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.674
      (0.00%)
      		0
      AAGRAfrican Agriculture Holdings Inc
      $ 0.1629
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 63.09
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 1.57
      (0.00%)
      		0
      AACIArmada Acquisition Corporation I
      $ 11.30
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.674
      (0.00%)
      		0
      AAGRAfrican Agriculture Holdings Inc
      $ 0.1629
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 63.09
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 1.57
      (0.00%)
      		0
      AACIArmada Acquisition Corporation I
      $ 11.30
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.674
      (0.00%)
      		0

      Discussion

      View Full Feed
      Margin Buu Margin Buu 2 seconds ago
      Thanks for pointing out Leg-ends hypocrisy. He’s a spreader of FUD and not very good at it.
      NWBO
      Jack Torrance Jack Torrance 2 minutes ago
      I personally think 80%.
      MNMD
      CaptainObvious CaptainObvious 7 minutes ago
      "The reality about this stock is nobody knows anything....

      ...something I will bet a lot on is that the stock will not get above $1"
      NWBO
      Capt_Smith77 Capt_Smith77 30 minutes ago
      I'll believe in their backing of G42 when it doesn't amount to diluting shareholders, and there's an actual appreciation in the stock price. To date, the company's financing has done nothing but reduce shareholder value.

      Now on a more positive note, at least we haven't seen any recen
      VRSSF
      tedgoeseast tedgoeseast 49 minutes ago
      Everyone else has already seen this on the news today it's nothing new
      Sonar Sonar 54 minutes ago
      The only document related to Mr Norward and Oceanwide Plaza:
      https://www.myvisajobs.com/Visa-Sponsor/Tohigh-Construction-Investment/1236463.htm
      Relationship between Mr Norward and ESSGCorp.net
      https://investorshub.advfn.com/uimage/uploads/2024/7/24/wzxfcScreenshot_2024-07-24_094
      JBZY
      Capt_Smith77 Capt_Smith77 54 minutes ago
      Of course they're not still testing the software. At least not anyone but maybe Blue Yonder, which was the last one to join the Beta program, IIRC.

      Still, the company has advertised them all as partnerships, which they are not. They've even reworded how things are said in recent PRs
      VRSSF
      snow snow 57 minutes ago
      lishious It is usually a trade-off I think. By raising prices a company will usually sell less but may even so make more money in some cases. Long-term it may or may not be a good idea to just have a very slim profit margin if that makes it possible to increase sales fast. It all depends on the circ
      IQST
      Methinks Methinks 59 minutes ago
      Kamala has a distinct advantage over Trump because she is bi-continental. The genes of people from different continents are slightly different and when these different people have children, it seems that the best genes are often used in the offspring creating very clever people. Obama was the same a
      snow snow 1 hour ago
      quigley We could not disagree more! Time will show who is closest to the truth.
      IQST
      littlejohn littlejohn 1 hour ago
      Typhoon Gaemi forecast track is for Wednesday

      pm landfall of about 6 PM EST...U.S...

      which is about 12 AM GMT on Thursday

      in Taiwan...

      https://www.worldtimebuddy.com/

      https://www.google.com/maps/@24.655501,119.6369319,7z/data
      The Danish Dude The Danish Dude 1 hour ago
      Due diligence on Ihub these days seems to be a western by John Ford

      😂
      NWBO
      pickthemright pickthemright 1 hour ago
      No he means you !
      ALPP
      Wise Man Wise Man 1 hour ago
      The ultimate dividend rate on the cumulative SPS has yet to be assessed.
      Presumably, the terms and conditions of the original UST backup of the enterprises will prevail, as part of the Charter-dynamics, "at a rate that takes into consideration the Treasury yields as of the end of the month pr
      FNMA
      spahibiscusindia spahibiscusindia 1 hour ago
      Thank you for this information. I am sharing a https://www.spahibiscusindia.com/ luxury spa service in India .
      SPTY
      snow snow 2 hours ago
      RD What does the following mean? "Apparently the amount is pending in the BoA account?" If there is just another delay of 5 days or so that is peanuts compared with a delay in your and other employees` remuneration of more than a year.
      ITUP
      nickmerck nickmerck 2 hours ago
      sector rotation. wait for EWI to level out, then we'll be in free-fall again :)
      RCAT
      jeunke22 jeunke22 2 hours ago
      Very encouraging to see that our new Board Member ( please remember that Lebby was boardmember before being appointed to the Executive Team) Yves LeMaitre is receiving congratulations from reputable industry leaders from Tier 1 companies to his new appointment. Having a great network and being recog
      LWLG
      lodas lodas 2 hours ago
      yo ron???.....do you have anymore updates on that well documented Duel Track D.C. case where WMI was awarded 309 billion dollars by Judge Collyer for RICO damages against WMI??....I kind of lost track of the message you might have posted to verify your assertion.... TIA..... Lodas
      COOP
      bwrbad bwrbad 2 hours ago
      interesting
      https://finance.yahoo.com/news/7-quantum-computing-stocks-could-112500343.html
      RGTI
      The ELTP King The ELTP King 2 hours ago
      Purdue Pharma L.P. et al v. Accord Healthcare Inc. et al

      July 23, 2024
      -Notice of Appearance filed by Gavin B. Parsons on behalf of All Defendants. (Parsons, Gavin)
      -Notice of Appearance filed by William Gabriel Pagan on behalf of All Defendants. (Pagan, William)
      ELTP

      Your Recent History

      TSX
      MDNA
      Medicenna Therapeutics
      Delayed Upgrade Clock